Mesa Laboratories (MLAB) Asset Writedowns and Impairment (2017 - 2019)

Mesa Laboratories has disclosed Asset Writedowns and Impairment across 3 years of filings, most recently posting $276000.0 for Q4 2019.

• Asset Writedowns and Impairment for Q4 2019 came in at $276000.0, down 92.48% year-over-year; the trailing twelve-month figure through Mar 2020 was $5.0 million (down 72.84% YoY), and the FY2024 annual result was $274.5 million, changed N/A from the prior year.
• Asset Writedowns and Impairment came in at $276000.0 for Q4 2019 at Mesa Laboratories, down from $1.1 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $13.8 million in Q4 2017 to a low of $276000.0 in Q4 2019.
• The 3-year median for Asset Writedowns and Impairment is $2.4 million (2018), against an average of $4.7 million.
• Across the five-year window, Asset Writedowns and Impairment sank 73.45% in 2018 and sank 92.48% in 2019, its largest moves.
• Mesa Laboratories' Asset Writedowns and Impairment stood at $13.8 million in 2017, then tumbled by 73.45% to $3.7 million in 2018, then tumbled by 92.48% to $276000.0 in 2019.
• The last three Asset Writedowns and Impairment figures came in at $276000.0 (Q4 2019), $1.1 million (Q1 2019), and $3.7 million (Q4 2018), per Business Quant data.